Pancreatic Cancer Research

ResearcherKaohsiung Medical UniversityActive in the last 2 years

Hui‐Jen Tsai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5246-5748; OpenAlex author ID A5041219670. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 3 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 9

  1. A New CA19-9 Cutoff Value Identifies Lewis Antigen Status and Refines Prognostic Stratification in PDAC. Co-author DOI 10.1158/1078-0432.ccr-25-4564↗
  2. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan. Co-author DOI 10.1186/s12929-024-01008-7↗
  3. Improved survival with induction chemotherapy and conversion surgery in locally advanced unresectable pancreatic cancer: a single institution experience. Co-author PMID 35693078↗
  4. No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol. Co-author DOI 10.1038/s41598-021-94111-w↗
  5. The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort. Co-author DOI 10.1038/s41598-020-64421-6↗
  6. Author Correction: The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort. Co-author DOI 10.1038/s41598-020-77250-4↗
  7. Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan. Co-author DOI 10.1186/s12929-020-00664-9↗
  8. Environmental Risk Factors of Pancreatic Cancer. Co-author DOI 10.3390/jcm8091427↗
  9. The incidence and survival of pancreatic cancer by histology, including rare subtypes: a nation-wide cancer registry-based study from Taiwan. Last author DOI 10.1002/cam4.1795↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Li‐Tzong Chen · 8 shared papers, 2018–2026 · strength 1.10
  2. Yan‐Shen Shan · 7 shared papers, 2018–2026 · strength 1.01
  3. Nai‐Jung Chiang · 7 shared papers, 2020–2026 · strength 1.00
  4. Yung‐Yeh Su · 5 shared papers, 2020–2026 · strength 0.80
  5. Ying‐Jui Chao · 5 shared papers, 2020–2026 · strength 0.73
  6. Jeffrey Shu-Ming Chang · 4 shared papers, 2018–2021 · strength 0.50
  7. Siao Muk Cheng · 2 shared papers, 2024–2026 · strength 0.41
  8. Chien‐Jui Huang · 2 shared papers, 2022–2024 · strength 0.30
  9. Ya‐Chin Hou · 1 shared paper, 2026 · strength 0.24
  10. Chia‐Ming Yeh · 1 shared paper, 2026 · strength 0.24
  11. Ping‐Jui Su · 1 shared paper, 2022 · strength 0.12
  12. Ting‐Kai Liao · 1 shared paper, 2022 · strength 0.12
  13. Yan-Shen Shan · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.